Global In Vitro Diagnostics (IVD) Market, By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), End-User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care, Others), Product & Service (Reagents, Instruments, and Software & Services), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
In vitro diagnostics (IVD) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of 585.81 billion and grow at a CAGR of 5.95% in the above-mentioned forecast period. Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases drives the in vitro diagnostics (IVD) market.
In Vitro Diagnostics are the type of tests which are performed on an individual’s blood/tissue sample. They are used to accurately test and diagnose diseases or any underlying conditions and are also helpful in maintaining constant monitoring over the patient’s health. Benefits of these diagnostic tests are that they help identify every individual’s best course of treatment.
Increasing adoption of fully automated instruments and automation in laboratories is the vital factor escalating the market growth, also rising awareness on personalized medicine and increasing adoption of point-Of-care testing are the major factors among others driving the in vitro diagnostics/IVD market. Moreover, rising development of condition-specific markers and tests, rising significance of companion diagnostics and rising growth opportunities in emerging countries will further create new opportunities for in vitro diagnostics/IVD market in the forecasted period of 2021-2028.
However, rising unfavorable reimbursement scenario and constant upgradation in regulations by the authorities are the major factors among others which will obstruct the market growth, while changing regulatory landscape and rising operational barriers faced in conducting diagnostic tests will further challenge the growth of In vitro diagnostics/IVD market in the forecast period mentioned above.
This in vitro diagnostics (IVD) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on In vitro diagnostics (IVD) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
In Vitro Diagnostics (IVD) Market Scope and Market Size
In vitro diagnostics (IVD) market is segmented on the basis of technique, application, end-user and product and service. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technique, In vitro diagnostics (IVD) market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others.
- Based on application, the In vitro diagnostics (IVD) market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others.
- Based on end-user, the In vitro diagnostics (IVD) market is segmented into standalone laboratory, hospitals, academic and medical schools, point of care, and others.
- The In vitro diagnostics (IVD) market is also segmented on the basis of product and service into reagents, instruments, and software and services.
Global In Vitro Diagnostics (IVD) Market Country Level Analysis
In vitro diagnostics (IVD) market is analysed and market size insights and trends are provided by country, technique, application, end-user and product and service as referenced above.
The countries covered in the In vitro diagnostics (IVD) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the In vitro diagnostics (IVD) market due to rising favorable government regulations, well-established diagnostic infrastructure, technological advancements in the field of in-vitro diagnostics, and the presence of key market players in this region. Asia-Pacific is the expected region in terms of growth in In vitro diagnostics (IVD) market due to rising presence of a large number of target populations along with improving healthcare infrastructure in this region.
The country section of the in vitro diagnostics (IVD) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
In vitro diagnostics (IVD) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for In vitro diagnostics (IVD) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the In vitro diagnostics (IVD) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and In Vitro Diagnostics (IVD) Market Share Analysis
In vitro diagnostics (IVD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to In vitro diagnostics (IVD) market.
The major players covered in the In vitro diagnostics (IVD) market report are F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Danaher, Abbott, Thermo Fisher Scientific Inc, Johnson & Johnson Services Inc., BD, Bio-Rad Laboratories Inc., Sysmex Corporation, bioMérieux SA, DiaSorin, Ortho Clinical Diagnostics, Agilent Technologies Inc., QIAGEN, Bayer AG, Hologic Inc., Cepheid, Diagnostica Stago S.A.S., Leica Biosystems Nussloch GmbH, Quidel Corporation, OraSure Technologies Inc., Beckman Coulter Inc., and ARKRAY Inc among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global In Vitro Diagnostics (IVD) Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.